An Awareness, Courage, and Love Intervention to Help Chinese Older Adults in the Post-pandemic Era

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorCaritas Institute of Higher Education

About this trial

The purpose of this study is to explore the potential effectiveness of a one-session online Awareness, Courage, and Love intervention for reducing loneliness, depression and anxiety symptoms, and enhancing social connectedness and subjective well-being among older adults. the study also aims to estimate the effect sizes of the Awareness, Courage, and Love intervention.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

aged 60 years or older and dwelling in the community;

able to communicate in Cantonese;

have access to the internet and videoconferencing devices such as a mobile phone;

able to give informed consent to participate.

Disqualifiers

severe emotional distress based on PHQ-4 screening assessment or presenting an imminent suicidal risk;

known history of autism, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia/significant cognitive impairment;

illiterate;

difficulty in communication.

Trial design

Design model

Parallel

Treatments tested in this trial

  • The Awareness, Courage and Love Intervention

    Behavioral

    Derived from Functional Analytic Psychotherapy (FAP), the Awareness, Courage, and Love (ACL) Intervention brings the FAP principles to a broader population. In the ACL model, awareness is defined as engaging in mindful awareness of one's self (feelings, needs, values), other individuals, and the context in which interactions are taking place. Courage is defined as engaging in authentic, vulnerable self-disclosures (e.g. struggles, appreciation), and asking for what one wants and needs. Love is defined as providing empathically accurate responsiveness, including provision of safety, validation, and giving the other person what they have asked for when possible.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Awareness, Courage, and Love interventionExperimental treatment 1 intervention
Group B: Waitlist control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Changes from Baseline on the Inclusion of Others in Self (IOS) at Immediately post-intervention and One-month post-intervention follow-up

The single-item Inclusion of Others in the Self (IOS) scale is to measure how close the respondent feels with another person or group. Respondents choose a pair of photos from seven with different degrees of overlap. Possible scores range from 1 (No overlap) to 7 (Most overlap).

Time frame
Baseline, Immediately post-intervention and One-month post-intervention follow-up

Secondary outcomes

1

Changes from Baseline on the 6-item de Jong Gierveld loneliness scale at Immediately post-intervention and One-month post-intervention follow-up

The 6-item De Jong Gierveld Loneliness Scale is a reliable and valid measurement instrument for overall, emotional, and social loneliness. The possible range of scores is from 0 (Least lonely) to 6 (Most lonely).

Time frame
Baseline, Immediately post-intervention and One-month post-intervention follow-up
2

Changes from Baseline on the Patient Health Questionnaire (PHQ-9) at Immediately post-intervention and One-month post-intervention follow-up

The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression over the last 2 weeks. The interpretation of total scores ranges from 1-4 (Minimal depression) to 20-27 (Severe depression).

Time frame
Baseline, Immediately post-intervention and One-month post-intervention follow-up
3

Changes from Baseline on the Generalized Anxiety Disorder 2-item (GAD-2) at Immediately post-intervention and One-month post-intervention follow-up

The GAD-2 is a very brief and easy to perform initial screening tool for generalized anxiety disorder over the last 2 weeks. The possible scores range from 0 to 6. Higher scores are associated with higher levels of anxiety. A score of 3 points or more suggests possible anxiety.

Time frame
Baseline, Immediately post-intervention and One-month post-intervention follow-up
4

Changes from Baseline on The World Health Organisation- Five Well-Being Index (WHO-5) at Immediately post-intervention and One-month post-intervention follow-up

The WHO-5 is a short self-reported measure of current mental wellbeing. The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.

Time frame
Baseline, Immediately post-intervention and One-month post-intervention follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: